A Minnesota seniors group sued nine major pharmaceutical manufacturers on Wednesday, alleging that the companies have conspired to keep U.S. medicine prices artificially high by blocking Canadian imports
AstraZeneca PLC, a pharmaceutical company, engages in the research, development, manufacture, and marketing of prescription pharmaceuticals, as well as the supply of healthcare services worldwide. It provides medicines designed to fight disease in areas of medical need, such as cancer, cardiovascular, gastrointestinal, infection, neuroscience, and respiratory. The company’s product portfolio includes Casodex, Arimidex, Faslodex, Nexium, Symbicort, Atacand, Crestor, Zomig, Seroquel. The British company Zeneca was incorporated in 1992 and changed its name to AstraZeneca PLC in 1999 when it merged with the Swedish company, Astra, to form AstraZeneca, one of the world leaders in the pharmaceutical industry. AstraZeneca PLC has its headquarters in London.
15 Stanhope Gate
London, W1K 1LN
Fax: 44 20 7304 5151
Florida’s Medicaid program will receive $807,826 from pharmaceutical company AstraZeneca as a result of a settlement with the attorney general.
Attorney General Charlie Crist says the company committed Medicaid fraud through the marketing and sale of the drug Zoladex for use in the treatment of prostate cancer.
Crist says AstraZeneca overcharged Medicaid for Zoladex by not including promotions, free goods, discounts, rebates and other reductions in the price paid by Medicaid
Anglo-Swedish drug giant AstraZeneca has agreed to pay $354.9m to settle charges it defrauded the US healthcare system.
The company admitted giving free samples of cancer drugs to doctors, who then billed Medicare for the full price